OBEZİTE VE ADİPOKİNLER

Sedat Motor; Mukadder Keskin; Recep Dokuyucu

doi:10.17944/mkutfd.16142

Letter to Editor

Obesity and Adipokines

Year 2014, Volume: 5 Issue: 18, 34 - 45, 03.03.2015

Sedat Motor Mukadder Keskin Recep Dokuyucu

https://doi.org/10.17944/mkutfd.16142

Cited By: 2

Abstract

Obesity is defined as an excessive increase in adipose tissue. Studies in recent years, white adipose tissue is revealed as an endocrine organ can produce and release several bioactive polypeptides known as adipokines. In these studies, the adipokines has been shown to play an important role in the development of diseases associated with obesity including insulin resistance, inflammation, hypertension, cardiovascular and metabolic disorders. In this review, obesity-related adipokines, cytokines and their functions are given information about

Keywords

Adipose tissue, Obesity, Adipokines, Cytokines

References

Dina C. New insights into the genetics of body weight. Curr Opin Clin Nutr Metab
Care 2008;11:378-384.
Reaven G, Abbasi F, McLaughlin T. Obesity, insulin resistance and cardiovascular
disease. Recent Prog Horm Res 2004;59:207-223.
Shamseddeen H, Getty JZ, Hamdallah IN, Ali MR. Epidemiology and economic
impact of obesity and type 2 diabetes. Surg Clin North Am 2001;91:1163-1172
Türkiye Beslenme ve Sağlık Araştırması 2010. http://ekutuphane.sagem.gov.tr/kitaplar
Jacobi D, Stanya KJ, Lee CH. Adipose tissue signaling by nuclear receptors in
metabolic complications of obesity. Adipocyte 2012;1(1):4-12
Nadir I, Oğuz D. Adipokinler. Güncel Gastroenteroloji Dergisi. 2009; 13; 107-109.
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional
cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
Mehta S, Farmer JA. Obesity and inflamation: A new look at an old problem. Curr
Atheroscler Rep 2007;9:134-138.
Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of
adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and
subcutaneous adipose tissues of obese humans. Endocrinology 2004;14:52273-52282.
Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB
protein: evidence for a peripheral signal linking adiposity and central neural networks.
Science 1995;269:546-549.
Chen G, Koyama K, Yuan X, Lee Y, Zhou YT, O'Doherty R, Newgard CB, Unger
RH. Disappearance of body fat in normal rats induced by adenovirus-mediated leptin
gene therapy. Proc Natl Acad Sci USA. 1996 10;93(25):14795-14799.
Orci L, Cook WS, Ravazzola M, Wang MY, Park BH, Montesano R, Unger RH.
Rapid transformation of white adipocytes into fat-oxidizing machines. Proc Natl Acad
Sci USA. 2004 17;101(7):2058-2063.
Vazquez-Vela MEF, Torres N, Tovar AR. White adipose tissue as endocrine organ
and its role in obesity. Arch Med Res 2008;39:715-728.
Coppari R, Bjorbaek C. Leptin revisited: its mechanisms of action and potential for
treating diabetes. Nat Rev Drug Discov 2012;11:692-708
Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley
GB, Bao C, Noble PW, Lane MD, Diehl AM. Leptin regulates proinflammatory
immune responses. FASEB J 1998;12:57-65.
Konstantidines S, Schafer K, Koschnick S, Loskutoff DJ. Leptin-dependent platelet
aggregation and arterial thrombosis suggests a mechanism of atherothrombotic disease
in obesity. J Clin Invest 2001;108:1533-1540.
Scherer PE, Williams S, Flogiano M, Baldini G, Lodish HF. A novel serum protein
similar to C1q, produced exclusively by adipocytes. J Biol Chem 1995;270:26746–
-
Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, et al.
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating
AMP-activated protein kinase. Nat Med 2002;8:1288-1295.
Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev
;26:439-451.
Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Adipocytederived
plasma protein, adiponectin, suppresses lipid accumulation in class A
scavenger receptors expression in human monocyte-derived macrophages. Circulation
;103:1057-1063.
Fernandez-Real JM, Lopez-Bermejo A, Casamitjana R, Ricart W. Novel interactions
of adiponectin with the endocrine system and inflammatory parameters. J Clin
Endocrinol Metab 2003;88:2714-2718.
Turer AT, Khera A, Ayers CR, Turer CB, Grundy SM, Vega GL, Scherer PE. Adipose
tissue mass and location affect circulating adiponectin levels. Diabetologia
;54:2515-2524.
Juan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor
levels. A possible link between insulin resistance and atherothrombosis.
Diabetologia 1991;34:457-462.
Appel SJ, Harrell JS, Davenport ML. Central obesity, the metabolic syndrome and
plasminogen activator inhibitor-1 in young adults. J Am Acad Nurse Pract
;17:535-541.
Siklova-Vitkova M, Klimcakova E, Polak J, Kovacova Z, Tencerova M, Rossmeislova
L, et al. Adipose tissue secretion and expression of adipocyte-produced and
stromavascular fraction-produced adipokine vary during multiple phases of weightreducing
dietary intervention in obese women. J Clin Endocrinol Metab
;97:1176-1181.
Ma LJ, Mao SL, Taylor KL, Kanjanabuch T, Guan Y, Zhang Y, Brown NJ, Swift LL,
McGuinness OP, Wasserman DH, Vaughan DE, Fogo AB. Prevention of obesity and
insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes.
;53(2):336-346.
Gurlek A, Bayraktar M, Kirazli S: Increased plasminogen activator inhibitor-1 activity
in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
Diabetes Care. 2000;23(1):88-92.
Festa A, D’Agostino R Jr, Tracy RP, Haffner SM: Elevated levels of acute-phase
proteins and plasminogen activator inhibitor-1 predict the development of type 2
diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 2002;51:1131-1137.
Massiera F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM, Quignard-
Boulange A, Negrel R, Ailhaud G, Seydoux J, Meneton P, Teboul M. Adipose
angiotensinogen is involved in adipose tissue growth and blood pressure regulation.
FASEB J 2001;15:2727-2729.
Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH. The serum angiotensinogen
concentration and variants of the angiotensinogen gene in white and black children. J
Clin Invest. 1995;95(3):948-953.
Forrester T, McFarlane-Anderson N, Bennet F, Wilks R, Puras A, Cooper R, Rotimi
C, Durazo R, Tewksbury D, Morrison L. Angiotensinogen and blood pressure among
blacks: findings from a community survey in Jamaica. J Hypertens. 1996;14(3):315-
32. Yiannikouris F, Karounos M, Charnigo R, English VL, Rateri DL, Daugherty A, and
Cassis LA. Adipocyte-specific deficiency of angiotensinogen decreases plasma
angiotensinogen concentration and systolic blood pressure inmice. Am J Physiol
Regul Integr Comp Physiol 2012;302:R244-R251.
Lin Y, Rajala MW, Berger JP, Moller DE, Barzilai N, Scherer PE. Hyperglycemia
induced production of acute phase reactants in adipose tissue. J Biol Chem
;276:42077-42083.
Poitou C, Viguerie N, Cancello R, De Matteis R, Cinti S, Stich V, Coussieu
C, Gauthier E, Courtine M, Zucker JD, et al. Serum amyloid A: production by human
white adipocytes and regulation by obesity and nutrition. Diabetologia 2005;48:519-
-
Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, Pepine CJ, et
al. Serum amyloid A as a predictor of coronary heart disease and cardiovascular
outcome in women: the National Heart, Lung, and Blood Institute Sponsored
Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004;109:726-732.
Ogasawara K, Mashiba S, Wada Y, et al. A serum amyloid A and LDL complex as a
new prognostic marker in stable coronary artery disease. Atherosclerosis
;174:349–56.
King VL, Thompson J, Tannock LR. Serum amyloid A in atherosclerosis. Curr Opin
Lipidol 2011;22:302-307.
Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes.
Nature 2001;409:307-312.
Verma S, Li SH,Wang CH, et al. Resistin promotes endothelial cell activation: further
evidence of adipokine–endothelial interaction. Circulation 2003;108:736-740.
Kusminski CM, Meternan PG, Kumar S. Role of resistin in obesity, insülin resistance
and Type II diabetes. Clinical Science 2005;109:243-256.
Hirai K, Hussey HJ, Barber MD, Price SA, Tisdale MJ. Biological evaluation of a
lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res
;58:2359-2365.
Sanders PM, Tisdale MJ. Effect of zinc-α2-glycoprotein (ZAG) on expression of
uncoupling proteins in skeletal muscle and adipose tissue. Cancer Lett 2004;212:71-
-
Gong FY, Zhang SJ, Deng JY, et al. Zinc-alpha2-glycoprotein is involved in
regulation of body weight through inhibition of lipogenic enzymes in adipose tissue.
Int J Obes 2009;33:1023-1030.
Yeung DCY, Lam KSL, Wang Y, Tso AW, Xu A. Serum zinc-α2-glycoprotein
correlates with adiposity, triglycerides, and the key components of the metabolic
syndrome in Chinese subjects. J Clin Endocrinol Metab 2009;94:2531-2536.
Ashley EA, Powers J, Chen M, et al. The endogenous peptide apelin potently
improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res
;65:73-82.
Wei L, Hou X, Tatemoto K. Regulation of apelin mRNA expression by insülin and
glucocorticoids in mouse 3T3-L1 adipocytes. Regul Pept 2005;132:27-32.
Yu S, Zhang Y, Li MZ, et al. Chemerin and apelin are positively correlated with
inflammation in obese type 2 diabetes patients. Chin Med J 2012;125:3440-3444.
Kloting N, Graham TE, Berndt J, et al. Serum retinol-binding protein is more highly
expressed in visceral than in subcutaneous adipose tissue and is a marker of intraabdominal
obesity fat mass. Cell Metab 2007;6:79-87.
Graham TE, Yang Q, Bluher M, et al. Retinol binding protein 4 contributes to insülin
resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552-2563.
Hammarstedt A, Graham TE, Kahn BB. Adipose tissue dysregulation and reduced
insulin sensitivity in non-obese individuals with enlarged abdominal adipose cells.
Diabetol Metab Syndr 2012 19;4(1):42. doi: 10.1186/1758-5996-4-42.
Hida K, Wada J, Eguchi J, et al. Visceral adipose tissue-derived serine protease
inhibitor: a unique insulin-sensititizing adipocytokine in obesity. Proc Natl Acad Sci
USA 2005;102:10610-10615.
Chang HM, Lee HJ, Park HS, et al. Effects of weight reduction on serum vaspin
concentrations in obese subjects: modifications by insulin resistance. Obesity
;18:2105-2110.
Kloting N, Kovacs P, Kern M, et al. Central vaspin administration acutely reduces
food intake and has sustained blood glucose-lowering effects. Diabetologia
;54:1819-1823.
Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral
fat that mimics the effects of insulin. Science 2005;307:426-430.
Chang YH, Chang DM, Lin KC, Shin SJ, Lee YJ. Visfatin in overweight/obesity type
diabetes mellitus insulin resistance, metabolic syndrome and cardiovascular
diseases: a meta-analysis and systematic review. Diabetes Metab Res Rev
;27:515-527.
Kim SR, Bae YH, Bae SK, et al. Visfatin enhances ICAM-1 and VCAM-1 expression
through ROS-dependent NF-kappaB activation in endothelial cells. Biochim Biophys
Acta 2008;1783:886-895.
Yang RZ, Lee MJ, Hu H, et al. Identification of omentin as a novel depot-specific
adipokine in human adipose tissue: possible role in modulating insulin action. Am J
Physiol Endocrinol Metab 2006;290:E1253-1261.
Zhong X, Li X, Liu F, Tan H, Shang D. Omentin inhibits TNF-α-induced expression
of adhesion molecules in endothelial cells via ERK/NF-kB pathway. Biochem
Biophys Res Commun 2012;425:406-410.
Zhong X, Zhang HY, Tan H, et al. Association of serum omentin-1 levels with
coronary artery disease. Acta Pharmacol Sin 2011;32:873878.
Wittamer V, Franssen JD, Vulcano M, et al. Specific recruitment of antigenpresenting
cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp
Med 2003;198:977-985.
Goralski KB,McCarthy TC, Hanniman EA, et al. Chemerin, a novel adipokine that
regulates adipogenesis and adipocyte metabolism. J Biol Chem 2007;282:28175-
62. Takahashi M, Takahashi Y, Takahashi FN, et al. Chemerin enhances insulin signaling
and potentiates insulin-stimulated glucose uptake in 3T3-L1adypocytes. FEBS Lett
;582:573-578.
Sell H, Laurencikiene J, Taube A, et al. Chemerin is a novel adipocyte-derived factor
inducing insulin resistance in primary human skeletal muscle cells. Diabetes
;58:2731-2740.
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a
growth hormone-releasing acylated peptide from stomach. Nature. 1999 Dec 9; 402
(6762): 656-60.
Aydoğan A, Akküçük S, Özkan OV, Aydın M, Motor S, Uğur M, Oruç C, Yönden Z.
The Protective Effects Of Peptide YY And Ghrelin In Acute Biliary Pancreatitis. Acta
Medica Mediterranea, 2014, 30(2): 323-327
Der Lely A.J, Ghigo E. Non-acylated ghrelin counteracts the metabolic but not the
neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab
;89: 3062-3065.
Tombran-Tink J, Chader GG, Johnson LV. PEDF: a pigment epithelium-derived
factor with potent neuronal differentiative activity. Experimental eye research.
;53(3):411-4.
Yüksel R. Homozigot Hbss Erişkin Orak Hücre Anemili Hastalarda Serum PEDF
Düzeyleri ile hsCRP Arasındaki ilişkinin incelenmesi. Uzmanlık Tezi, Hatay: Mustafa
Kemal Üniversitesi Tayfur Ata Sökmen Tıp Fakültesi, Tıbbi Biyokimya AD, 2014
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW.
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest
;112:1796-1808.
Lumeng C, Bodzin J, Saltiel A. Obesity induces phenotypic switch in adipose tissue
macrophage polarization. J Clin Invest 2007;117:175-184.
Lorenzo M, Fernandez-Veledo S, Vila-Bedmar R, et al. Insulin resistance induced by
tumor necrosis factor-alpha in myocytes and brown adipocytes. J Anim Sci
;86:E94-104.
Romanatto T, Roman EA, Arruda AP, et al. Deletion of the tumor necrosis factor-α
receptor 1 (TNFR1) protects against diet-induced obesity by means of increased
thermogenesis. J Biol Chem 2009;284:36213-36222.
Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis
factor-alpha: direct role in obesity linked-insulin resistance. Science 1993;259:87-91.
Bruun JM, Lihn AS, Verdich C, et al. Regulation of adiponectin by adipose tissuederived
cytokines: in vivo and in vitro investigations in humans. Am J Physiol
Endocrinol Metab 2003;285:E257-533.